Blood–Brain Barrier Permeability Prediction: Machine Learning, Graph Neural Networks, and Protonation-State Robustness

Blood–brain barrier permeability (BBBP) prediction is important for central nervous system (CNS) drug discovery, yet the relative performance of traditional molecular feature-based models and graph neural networks (GNNs), as well as the sensitivity of BBBP predictions to molecular protonation states, remains insufficiently characterized. Here, we curated the public OmniBBBP dataset through structural deduplication, label-conflict resolution, and removal of compounds overlapping with an external benchmark, yielding 8836 compounds for model development. Four traditional machine learning (ML) models and three GNN architectures (GCN, GAT, and PNA) were evaluated using repeated similarity-cluster cross-validation (CV). XGBoost combining 173 RDKit descriptors with a 1024-bit Morgan fingerprint achieved the strongest overall performance, with accuracies of 0.893 and 0.860 and Matthews correlation coefficients (MCCs) of 0.765 and 0.720 on the fixed test set and 200-compound external benchmark, respectively. Its benchmark performance was comparable to that reported for the deep learning model BBBP-Atlas, whereas PNA showed complementary performance among compounds with low structural similarity to the training set. To investigate protonation-state sensitivity, benchmark compounds were expanded into 962 protomeric structures, and XGBoost was retrained using a protomer-expanded training set while retaining the same molecular features and hyperparameters. Protomer-expanded training increased benchmark accuracy from 0.830 to 0.850 and MCC from 0.660 to 0.701, indicating improved robustness to alternative protonation-state representations. Overall, these results demonstrate that descriptor- and fingerprint-based XGBoost provides a competitive BBBP classification baseline under the present data and evaluation conditions and that incorporating alternative protomeric representations during training can further improve prediction robustness.

Authors

Institutions

Publication Details

Journal
Molecules
Published
2026-11-17
DOI
https://doi.org/10.3390/molecules31224164
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Blood–Brain Barrier Permeability Prediction: Machine Learning, Graph Neural Networks, and Protonation-State Robustness

Chao Yang, Xuhang Dai, Bocheng Xie, Pengwei Xiao et al.
3 links
Molecules
Computational Drug Discovery Methods
article

Blood–Brain Barrier Permeability Prediction: Machine Learning, Graph Neural Networks, and Protonation-State Robustness

Chao Yang, Xuhang Dai, Bocheng Xie, Pengwei Xiao, Dongjing Yang
article en

Abstract

Blood–brain barrier permeability (BBBP) prediction is important for central nervous system (CNS) drug discovery, yet the relative performance of traditional molecular feature-based models and graph neural networks (GNNs), as well as the sensitivity of BBBP predictions to molecular protonation states, remains insufficiently characterized. Here, we curated the public OmniBBBP dataset through structural deduplication, label-conflict resolution, and removal of compounds overlapping with an external benchmark, yielding 8836 compounds for model development. Four traditional machine learning (ML) models and three GNN architectures (GCN, GAT, and PNA) were evaluated using repeated similarity-cluster cross-validation (CV). XGBoost combining 173 RDKit descriptors with a 1024-bit Morgan fingerprint achieved the strongest overall performance, with accuracies of 0.893 and 0.860 and Matthews correlation coefficients (MCCs) of 0.765 and 0.720 on the fixed test set and 200-compound external benchmark, respectively. Its benchmark performance was comparable to that reported for the deep learning model BBBP-Atlas, whereas PNA showed complementary performance among compounds with low structural similarity to the training set. To investigate protonation-state sensitivity, benchmark compounds were expanded into 962 protomeric structures, and XGBoost was retrained using a protomer-expanded training set while retaining the same molecular features and hyperparameters. Protomer-expanded training increased benchmark accuracy from 0.830 to 0.850 and MCC from 0.660 to 0.701, indicating improved robustness to alternative protonation-state representations. Overall, these results demonstrate that descriptor- and fingerprint-based XGBoost provides a competitive BBBP classification baseline under the present data and evaluation conditions and that incorporating alternative protomeric representations during training can further improve prediction robustness.

MoleculesVol. 31(22)
Southern University of Science and Technology (CN), Shenzhen University of Advanced Technology (CN), New York University (US)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon